ArticleCancer research communications2022

GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumors.

Valentino Clemente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.